HAL (France)open access
Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review
FDA, EMA, 1, MHRA, First-in-class, Drug development, Novel drug approvals, 0
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 288237
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.